20 (AIDX) Change in Accured Expenses (2025 - 2026)
20's (AIDX) quarterly Change in Accured Expenses came in at -$202448.0 in Q1 2026, down 27457.84% YoY from N/an in Q1 2025, and down 27457.84% on a QoQ basis from $740.0 in Q1 2025.
20 (AIDX) Change in Accured Expenses (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Change in Accured Expenses data on file, last reported at -$202448.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | 20 | 5.56 Mn | 1.01 Mn | 304,727.00 | 172,565.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202,448.00 |
| Mar 31, 2026 | -202,448.00 |
| Mar 31, 2025 | 740.00 |
| Mar 31, 2025 | 740.00 |